Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hidetoshi Yasuda"'
Autor:
Yuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, Ryo Naito, Takuma Koike, Soshi Moriya, Hidetoshi Yasuda, Takehiro Funamizu, Shinichiro Doi, Hirohisa Endo, Hideki Wada, Manabu Ogita, Tomotaka Dohi, Takatoshi Kasai, Kikuo Isoda, Shinya Okazaki, Katsumi Miyauchi, Tohru Minamino
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Since the complication of diabetes mellitus (DM) is a risk for adverse cardiovascular outcomes in patients with coronary artery disease (CAD), appropriate risk estimation is needed in diabetic patients following percutaneous coron
Externí odkaz:
https://doaj.org/article/533d9649b08c4fb29e7f00a6866c1d63
Autor:
Yuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, Takuma Koike, Hidetoshi Yasuda, Takehiro Funamizu, Shinichiro Doi, Hirohisa Endo, Hideki Wada, Ryo Naito, Manabu Ogita, Tomotaka Dohi, Takatoshi Kasai, Kikuo Isoda, Shinya Okazaki, Katsumi Miyauchi, Tohru Minamino
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Dipeptidyl-peptidase-4 inhibitors (DPP4i) have been the most used antidiabetic medications worldwide due to their good safety profiles and tolerability with a low risk of hypoglycemia, however, large cardiovascular outcome trials (CVOTs) hav
Externí odkaz:
https://doaj.org/article/cdafe522dcad42c38fe4b89b94602b73
Autor:
Tatsuya Fukase, Tomotaka Dohi, Takuma Koike, Hidetoshi Yasuda, Mitsuhiro Takeuchi, Norihito Takahashi, Yuichi Chikata, Hirohisa Endo, Shinichiro Doi, Hiroki Nishiyama, Iwao Okai, Hiroshi Iwata, Shinya Okazaki, Katsumi Miyauchi, Hiroyuki Daida, Tohru Minamino
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 545-554 (2022)
Abstract Aims Little is known about the long‐term outcomes of β‐blockers use in patients with coronary artery disease (CAD) without myocardial infarction (MI) and reduced ejection fraction (rEF). However, more attention should be paid to the ora
Externí odkaz:
https://doaj.org/article/8783e2ea76394fe997f6b47cf7f20704
Publikováno v:
CJC Open, Vol 4, Iss 11, Pp 994-995 (2022)
Externí odkaz:
https://doaj.org/article/512f373164cc4d78bc94c4a9aebfb79a
Autor:
Takuma Koike, Hiroshi Iwata, Yuichi Chikata, Shinichiro Doi, Ryo Naito, Hidetoshi Yasuda, Takehiro Funamizu, Hirohisa Endo, Sakiko Miyazaki, Shinya Okazaki, Ryosuke Higuchi, Itaru Takamisawa, Kei Sato, Harutoshi Tamura, Hiroaki Yokoyama, Tetsuya Tobaru, Shuichiro Takanashi, Minoru Tabata, Tohru Minamino
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 2, p 729 (2023)
Pulmonary hypertension (PH) is a common complication of aortic stenosis (AS). Despite the established association between PH and poor outcomes in patients with AS, the prognostic implication of a change in PH after transcatheter aortic valve implanta
Externí odkaz:
https://doaj.org/article/7a98f04b003c4cbeabc00b01df038fff
Autor:
Tatsuya Fukase, Shinichiro Doi, Tomotaka Dohi, Takuma Koike, Ryota Nishio, Hidetoshi Yasuda, Mitsuhiro Takeuchi, Norihito Takahashi, Yuichi Chikata, Hirohisa Endo, Hiroki Nishiyama, Iwao Okai, Hiroshi Iwata, Shinya Okazaki, Hiroyuki Daida, Satoru Suwa, Tohru Minamino, Katsumi Miyauchi
Purpose Asians often face the problems of clopidogrel resistance and East Asian paradox. This study aimed to evaluate the effects of P2Y12 inhibitors, including low-dose prasugrel 2.5 mg, on the P2Y12 reaction unit (PRU) in the chronic phase after pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77ae9cd776e37acbdb511ccc7860d4ee
https://doi.org/10.21203/rs.3.rs-2645338/v1
https://doi.org/10.21203/rs.3.rs-2645338/v1
Autor:
Yuichi Chikata, Hirohisa Endo, Tatsuya Fukase, Takuma Koike, Shinichiro Doi, Hidetoshi Yasuda, Hiroshi Iwata, Norihito Takahashi, Hiroki Nishiyama, Mitsuhiro Takeuchi, Shinya Okazaki, Tomotaka Dohi, Tohru Minamino, Katsumi Miyauchi, Hiroyuki Daida, Iwao Okai
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 545-554 (2022)
ESC Heart Failure
ESC Heart Failure
Aims Little is known about the long‐term outcomes of β‐blockers use in patients with coronary artery disease (CAD) without myocardial infarction (MI) and reduced ejection fraction (rEF). However, more attention should be paid to the oral adminis
Autor:
Hidetoshi Yasuda, Hiroshi Iwata, Takuma Koike, Yuichi Chikata, Takehiro Funamizu, Shinichiro Doi, Jun Shitara, Hirohisa Endo, Hideki Wada, Ryo Naito, Manabu Ogita, Tomotaka Dohi, Takatoshi Kasai, Shinya Okazaki, Katsumi Miyauchi, Hiroyuki Daida, Tohru Minamino
Publikováno v:
Circulation. 144
Introduction: The evidence-based optimal medical therapy has been encouraged in the treatment of patients with coronary artery disease. However, as follow-up periods are limited (-5 years) in the most of randomized trials, prognostic efficacy of drug
Autor:
Tohru Minamino, Yuichi Chikata, Manabu Ogita, Katsutoshi Miyosawa, Hidetoshi Yasuda, Hiroshi Iwata, Takehiro Funamizu, Kikuo Isoda, Takatoshi Kasai, Hideki Wada, Shinichiro Doi, Tomotaka Dohi, Shinya Okazaki, Katsumi Miyauchi, Hirohisa Endo, Takuma Koike, Ryo Naito
Background: Dipeptidyl-peptidase-4 inhibitors (DPP4i) have become one of the most used antidiabetic medications worldwide due to their good safety profiles and tolerability with a low risk of hypoglycemia, however, no large cardiovascular outcome tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cf2a1237f78e4d851dd5e7db24b6192
https://doi.org/10.21203/rs.3.rs-730348/v1
https://doi.org/10.21203/rs.3.rs-730348/v1